ZHI Florida Inc. Now Offering Its Demonstrated Proprietary Technology for Transdermal Patch Delivery of CBD – World News ReportPosted by On


ZHI now offering all global manufacturers interested in becoming a Licensee, its proprietary technology for quantitative and proven Transdermal delivery of CBD.

We are thrilled with our new lead product, The ZT Patch™, designed to deliver 21.2mg of CBD from hemp. We have validated all data with Kaycha Labs, an independent testing lab.”

— Robert Galler, President

LAKE WORTH, FLORIDA, US, August 17, 2022 /EINPresswire.com/ — Transdermal technology offers an easy-to-use method of delivering a consistent, steady dose of an active ingredient. The transdermal delivery methodology provides unparalleled safety and control, allowing product use to be discontinued anytime, making accidental overdosing almost impossible.

Robert C. Galler, President & Chairman of ZHI, stated, “We are thrilled with our new lead product, The ZT Patch™, designed to deliver 21.2mg of CBD from hemp. We have validated performance with Kaycha Labs, an independent testing lab. The results of a bioavailability study determined that volunteers who wore the ZT Patch™ for 24 hours showed almost complete delivery of the targeted dosage directly into the body. All ZT Patches™ maintained effective adhesion throughout the test duration.” Galler continued, “We are very excited about our proprietary technology, and I believe it will make the industry much safer by providing better predictive results for all users. This is a breakthrough for…

Original Author Link click here to read complete story..

News

Kaycha LabsZT Patch

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.